COLL
Collegium Pharmaceutical, Inc.Healthcare · $713M market cap
Verdict
Share price
$22.02
close of Oct 3, 2026
Fair value
$29.43
Sticker Price
Payback Price
$11.77
buy price
COLL is Undervalued: at $22.02 it trades 25% below its fair value of $29.43. Its buy price (Payback Price) is $11.77, 47% below today's price. Business quality is strong: all 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
5 of 5 clear the 10% bar. What are the Big Five?
Follow COLL
Get notified when it reaches its buy price of $11.77. Free.
Create a free accountSuperinvestors
1 of the investors we track holds COLL. In Q2 2026, 1 added. Who we track
Moves in Q2 2026
Added: Third Avenue Management
About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular…
Drug Manufacturers - Specialty & Generic
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works